Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease.
D001281:Atrial Fibrillation / Q000150:complications; D001777:Blood Coagulation / Q000187:drug effects; D001792:Blood Platelets; D002470:Cell Survival / Q000187:drug effects; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008943:Mitral Valve; D010919:Placebos; D012214:Rheumatic Heart Disease / Q000150:complications*; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D013923:Thromboembolism / Q000150:complications / Q000188:drug therapy*; D014527:Uric Acid / Q000097:blood; D014859:Warfarin / Q000627:therapeutic use
D010919:Placebos; D014527:Uric Acid; D014859:Warfarin; D013442:Sulfinpyrazone